Covid-19 in South Africa
News
Politics
Opinion
Arts & Culture
Business
Education
Health
Webinars
Partner Features
Environment
Subscribe
Login
Search
Mail & Guardian
Africa\'s Best read
Subscribe
Mail & Guardian
Africa\'s Best read
Subscribe
Mail & Guardian
Africa\'s Best read
Login
Subscribe
Covid-19
News
Business
Politics
Environment
Opinion
Arts & Culture
Health
Education
Podcasts
Webinars
Partner Features
Search
Covid-19
News
Business
Politics
Environment
Opinion
Arts & Culture
Health
Education
Podcasts
Webinars
Partner Features
Search
Latest articles on
Ivermectin
How South Africa’s ivermectin use slips through the cracks
Aisha Abdool Karim
&
Joan Van Dyk
-
Advocates for ivermectin use severely flawed data
Philip Machanick
-
Dean Mcpherson: The poster boy for whiteness
Paddy Harper
-
People use social media posts to sell Ivermectin on the black market
Charma du Plessis
-
No silver bullet for Covid-19, but rather a cocktail
Philip Machanick
-
The vaccines arrive on Monday: Who will protect them and who will get them first?
Chris Bateman
-
False hope of ’miracle’ remedies
Philip Machanick
-
Ivermectin is not a miracle drug
Jan Bornman
-
Press Releases
Special Reports
How much is enough for retirement?
Special Reports
Economies thrive when men champion diversity, inclusion and gender equality and women lift as they rise
Special Reports
Encouraging equality and development with Standard Bank and the women’s Pro-Am series
Special Reports
National boy-focused GBV intervention launches
Special Reports
Youth vital for growing Gauteng together
Special Reports
Inter-School Forum: Youth Wellbeing
Special Reports
Prosus announces open-ended share repurchase programme
Special Reports
Naspers delivers strong revenue growth with profitable core operations; announces open-ended share repurchase programme
×